Avalo Therapeutics, Inc.
(AVTX - NASDAQ)
19,23 USD
📋 Profilo Aziendale

Avalo Therapeutics, Inc. is a precision medicine company in the clinical development phase, dedicated to identifying, advancing, and marketing specialized treatments for patients experiencing critical unmet medical needs across the fields of immunology, immuno-oncology, and rare genetic disorders.

|